429 related articles for article (PubMed ID: 30373614)
1. Current biomarkers of canine mammary tumors.
Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
[TBL] [Abstract][Full Text] [Related]
2. Research progress of good markers for canine mammary carcinoma.
Yang NY; Zheng HH; Yu C; Ye Y; Du CT; Xie GH
Mol Biol Rep; 2023 Dec; 50(12):10617-10625. PubMed ID: 37943402
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches.
Senhorello ILS; Terra EM; Sueiro FAR; Firmo BF; Anai LA; Goloni C; Canavari IC; Ampuero RAN; Pereira RS; Tinucci-Costa M
Vet Comp Oncol; 2020 Sep; 18(3):315-323. PubMed ID: 31664787
[TBL] [Abstract][Full Text] [Related]
4. CEA, CA 15-3, and miRNA expression as potential biomarkers in canine mammary tumors.
Jain M; Ingole SD; Deshmukh RS; Bharucha SV; Nagvekar AS; Gaikwad RV; Kharde SD
Chromosome Res; 2021 Jun; 29(2):175-188. PubMed ID: 33638118
[TBL] [Abstract][Full Text] [Related]
5. Investigation of HER2 expression in canine mammary tumors by antibody-based, transcriptomic and mass spectrometry analysis: is the dog a suitable animal model for human breast cancer?
Burrai GP; Tanca A; De Miglio MR; Abbondio M; Pisanu S; Polinas M; Pirino S; Mohammed SI; Uzzau S; Addis MF; Antuofermo E
Tumour Biol; 2015 Nov; 36(11):9083-91. PubMed ID: 26088453
[TBL] [Abstract][Full Text] [Related]
6. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a new triple-negative canine mammary cancer cell line.
Zhang H; Pei S; Zhou B; Wang H; Du H; Zhang D; Lin D
Tissue Cell; 2018 Oct; 54():10-19. PubMed ID: 30309498
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors.
Kato Y; Asano K; Mogi T; Kutara K; Teshima K; Edamura K; Tsumagari S; Hasegawa A; Tanaka S
J Vet Med Sci; 2007 Jan; 69(1):77-80. PubMed ID: 17283406
[TBL] [Abstract][Full Text] [Related]
9. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
10. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.
Queiroga FL; Perez-Alenza MD; González-Gil A; Silván G; Peña L; Illera JC
Vet Comp Oncol; 2017 Jun; 15(2):383-390. PubMed ID: 26463704
[TBL] [Abstract][Full Text] [Related]
11. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
[TBL] [Abstract][Full Text] [Related]
12. Breed-related differences in altered BRCA1 expression, phenotype and subtype in malignant canine mammary tumors.
Im KS; Kim IH; Kim NH; Lim HY; Kim JH; Sur JH
Vet J; 2013 Mar; 195(3):366-72. PubMed ID: 22901454
[TBL] [Abstract][Full Text] [Related]
13. CA15.3, CEA and LDH in dogs with malignant mammary tumors.
Campos LC; Lavalle GE; Estrela-Lima A; Melgaço de Faria JC; Guimarães JE; Dutra ÁP; Ferreira E; de Sousa LP; Rabelo ÉM; Vieira da Costa AF; Cassali GD
J Vet Intern Med; 2012; 26(6):1383-8. PubMed ID: 23113715
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-α, progesterone receptor, and c-
Kabir FML; DeInnocentes P; Agarwal P; Mill CP; Riese Nd DJ; Bird RC
J Vet Sci; 2017 Jun; 18(2):149-158. PubMed ID: 27515268
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a HER2-enriched canine mammary cancerous myoepithelial cell line.
Chen A; Ye S; Zheng J; Li J; Chen Z; Zhang Y; Li S
BMC Vet Res; 2023 Jan; 19(1):22. PubMed ID: 36717813
[TBL] [Abstract][Full Text] [Related]
16. Novel variations and loss of heterozygosity of BRCA2 identified in a dog with mammary tumors.
Yoshikawa Y; Morimatsu M; Ochiai K; Nagano M; Tomioka Y; Sasaki N; Hashizume K; Iwanaga T
Am J Vet Res; 2008 Oct; 69(10):1323-8. PubMed ID: 18828690
[TBL] [Abstract][Full Text] [Related]
17. Molecular carcinogenesis of canine mammary tumors: news from an old disease.
Klopfleisch R; von Euler H; Sarli G; Pinho SS; Gärtner F; Gruber AD
Vet Pathol; 2011 Jan; 48(1):98-116. PubMed ID: 21149845
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 expression, serum tumor markers, and immunohistochemistry in canine mammary tumors.
Ramadan ES; Salem NY; Emam IA; AbdElKader NA; Farghali HA; Khattab MS
Vet Res Commun; 2022 Jun; 46(2):377-388. PubMed ID: 34787777
[TBL] [Abstract][Full Text] [Related]
19. Common germline haplotypes and genotypes identified in BRCA2 exon 11 of dogs with mammary tumours and histopathological analyses.
Maués T; El-Jaick KB; Costa FB; Araujo GEF; Soares MVG; Moreira AS; Ferreira MLG; Ferreira AMR
Vet Comp Oncol; 2018 Sep; 16(3):379-384. PubMed ID: 29512278
[TBL] [Abstract][Full Text] [Related]
20. Somatic SNPs of the BRCA2 gene at the fragments encoding RAD51 binding sites of canine mammary tumors.
Ozmen O; Kul S; Risvanli A; Ozalp G; Sabuncu A; Kul O
Vet Comp Oncol; 2017 Dec; 15(4):1479-1486. PubMed ID: 28133886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
